Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis


Kalincik T., Havrdova E. K. , Horakova D., Izquierdo G., Prat A., Girard M., ...More

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, vol.90, no.4, pp.458-468, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 90 Issue: 4
  • Publication Date: 2019
  • Doi Number: 10.1136/jnnp-2018-319831
  • Title of Journal : JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
  • Page Numbers: pp.458-468

Abstract

Objective Oral immunotherapies have become a standard treatment in relapsing-remitting multiple sclerosis. Direct comparison of their effect on relapse and disability is needed.